The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/1878-0261.12965
PubMed Identifier: 33931939
Publication URI: http://europepmc.org/abstract/MED/33931939
Type: Journal Article/Review
Volume: 15
Parent Publication: Molecular oncology
Issue: 8
ISSN: 1574-7891